Metabolic rewiring of cancer cells induces metastasis via ERK5 but triggers recognition by NK cells
Zemiti, S.; Escayg, S.; Hay, B.; Bouzid, A.; Alexia, C.; Jacquard, C.; moustapha-abba-moussa, D.; Constantinides, M.; Coenon, L.; Allende-vega, N.; Campos-Mora, M.; Gerbal-Chaloin, S.; Anel, A.; De Toledo, M.; Bossis, G.; Aznar, A.-B.; Prieto, S.; Fisher, D.; Djouad, F.; Arribat, Y.; Rossi, J.-F.; Villalba, M.; Gitenay, D.
Show abstract
Metastasis is largely controlled by Natural Killer (NK) cell-mediated immune surveillance. To colonize new environments, cancer cells undergo epithelial to mesenchymal transition (EMT), which allows them to detach and migrate. EMT is fueled by fatty acid oxidation (FAO), which partially replaces glycolytic-based tumor metabolism. Whether metabolic rewiring affects the targeting of cancer cells by NK cells remains unknown. Here, we show that forcing solid cancer cells to perform FAO by inhibiting pyruvate dehydrogenase kinase 1 with dichloroacetate (DCA) activates extracellular signal-regulated kinase-5 (ERK5), triggering EMT and tumor cell migration and invasion. Concomitantly, FAO induces the expression of ligands that mediate NK cell recognition. Consequently, NK cells better infiltrated DCA-treated 3D tumor spheroids, where they exerted their cytotoxic effects. DCA-treated cells showed increased migration in a zebrafish model, whereas metastasis from mammary cancer cells grafted into immune-deficient mice was enhanced by DCA. These migrating/metastatic cells are preferentially killed by NK cells, which strongly limit their invasive potential. Hence, FAO promotes both metastasis and NK-mediated tumor surveillance, highlighting the Achilles heel of metastatic cells, which may offer new therapeutic opportunities. TeaserMetastasis recognition and killing by immune cells, such as NK cells, requires a metabolic shift that relies on lipid metabolism.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- PRMT1 regulates EGFR and Wnt signaling pathways and is a promising target for combinatorial treatment of breast cancer 94%
- Inhibition of the Myocardin-Related Transcription Factor pathway increases efficacy of Trametinib in NRAS-mutant melanoma cell lines 94%
- HERC1 regulates breast cancer cells migration and invasion 94%
Similar papers in this journal
- Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking LAIR-collagen interaction 95%
- Weakly migratory metastatic breast cancer cells activate fibroblasts via microvesicle-Tg2 to facilitate dissemination and metastasis 94%
- Reversing chemorefraction in colorectal cancer cells by controlling mucin secretion 94%
Similar papers in this journal
- Platinum chemotherapy induces lymphangiogenesis in cancerous and healthy tissues that can be prevented with adjuvant anti-VEGFR3 therapy 94%
- Modulated TRPC1 expression predicts sensitivity of breast cancer to doxorubicin and magnetic field therapy: segue towards a precision medicine approach. 94%
- Pan-TREM-1 versus macrophage-restricted TREM-1 blockade in cancer and other inflammatory pathologies 94%
Similar papers in this journal
- PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma 95%
- Immunomodulatory effects of tumor Lactate Dehydrogenase C (LDHC) in breast cancer 93%
- MiRNA-10b marks aggressive squamous cell carcinomas, and confers a cancer stem cell-like phenotype 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.